Records collected on Tuesday, June 16, 2026
54 records, grouped by source. Every entry links to the official source.
← Jun 15, 2026 · Jun 17, 2026 →
U.S. Department of Justice 7
- South Carolina woman pleads guilty to money laundering
- World Elder Abuse Awareness Day
- U.S. Attorney's Office Recognizes World Elder Abuse Awareness Day
- Former CFO Charged in Embezzlement Scheme and Immigration Fraud
- Vermont U.S. Attorney’s Office Marks World Elder Abuse Awareness Day
- U.S. Attorney’s Office for the Middle District of Florida Observes World Elder Abuse Awareness Day
- United States Attorney’s Office Recognizes World Elder Abuse Awareness Day
U.S. Securities and Exchange Commission 1
Company filings on SEC EDGAR 5
Federal Trade Commission 1
U.S. Food and Drug Administration 18
- FDA Class II: Guardian Drug Co. Inc. — HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets, 1000 mg, 160-count bottle, Haleon, Wa
- FDA Class II: Spectra Medical Devices, Llc — Lidocaine HCl Injection USP, 25x5 mL, Single-Dose Ampules, Rx Only, Distributed by: Spectra Medical
- FDA Class II: Guardian Drug Co. Inc. — HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VE
- FDA Class II: Guardian Drug Co. Inc. — CAREone, EXTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 750 mg, 96 chewable Tablets, Distributed
- FDA Class II: Guardian Drug Co. Inc. — HyVee, Extra Strength Antacid, Calcium Carbonate 750 mg, 96 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE
- FDA Class II: Guardian Drug Co. Inc. — TopCare health, ULTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE 1000mg, 72 CHEWABLE TABLETS, DIST
- FDA Class II: Guardian Drug Co. Inc. — GOODSENSE Ultra Strength, Antacid TABLETS, Calcium Carbonate 1000 mg, 72 Chewable Tablets, Distribut
- FDA Class II: Guardian Drug Co. Inc. — HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets, 750 mg, 330-count bottle, Haleon, War
- FDA Class II: Guardian Drug Co. Inc. — DISCOUNT drug mart, EXTRA STRENGTH, ANTACID TABLETS, Calcium Carbonate 750 mg, 96 Tablets, Distribut
- FDA Class II: Guardian Drug Co. Inc. — CAREone, ULTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 1000 mg, 72 chewable Tablets, Distributed
- FDA Class II: Guardian Drug Co. Inc. — EQUALINE ultra strength, antacid tablets, calcium carbonate 1000mg, 72 chewable tablets, DISTRIBUTED
- FDA Class II: Guardian Drug Co. Inc. — GOODSENSE Extra Strength, Antacid TABLETS, Calcium Carbonate 750 mg, 96 Chewable Tablets, Distribute
- FDA Class II: Guardian Drug Co. Inc. — EQUALINE extra strength, antacid tablets, calcium carbonate 750mg, 96 chewable tablets, DISTRIBUTED
- FDA Class II: Guardian Drug Co. Inc. — Good Neighbor Pharmacy, extra strength Antacid Calcium Carbonate 1000 mg, 72 chewable tablets, Distr
- FDA Class II: Guardian Drug Co. Inc. — Extra strength Antacid Calcium Carbonate 750 mg, chewable tablets, 96-count bottle, DISTRIBUTED BY C
- FDA Class II: Ascend Laboratories, LLC — Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Al
- FDA Class II: Asclemed USA Inc. — Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torran
- FDA Class II: Guardian Drug Co. Inc. — TopCare health, EXTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE 750mg, 96 CHEWABLE TABLETS, DISTR
International Trade Administration, U.S. Department of Commerce 5
- Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Parts Tariff Offset Program for Automobiles, MHDVs, and Engines
- Monosodium Glutamate From the People's Republic China: Final Results of Antidumping Duty Administrative Review; 2023-2024
- Chromium Trioxide From the Republic of Türkiye: Postponement of Final Determination of Sales at Less-Than-Fair-Value Investigation and Extension of Provisional Measures
- Glycine From India: Final Results of Countervailing Duty Administrative Review; 2023
- Certain Steel Nails From Taiwan: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Review; 2024-2025
Federal Energy Regulatory Commission 1
Other federal agencies (via the Federal Register) 4
- Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
- Fee Schedules; Fee Recovery for Fiscal Year 2026
- Information Collection Being Reviewed by the Federal Communications Commission Under Delegated Authority
- Application for Renewal of Authorization To Export Electric Energy; Mercuria Commodities Canada Corporation
Federal and state courts (via CourtListener) 12
- Booze v. State
- CLARK v. LEIGH (And Vice Versa)
- Glenn v. State
- Ween v. Village of New Lenox
- POM of PA v. Dep't of Rev.; Apl. of: Dep't of Rev.
- Eberly v. Eberly
- America First Legal Foundation v. Centers for Disease Control and Prevention
- Massimiliano Cali v. Donald Trump
- Am. Civ. Liberties Union of N.M. v. N.M. Corr. Dep't
- CALANDRELLA v. United States
- U.S. V.
- Whether the Equal Credit Opportunity Act Creates Disparate-Impact Liability